文献速递肝病

藤黄果单独或与绿茶联用可致中重度肝损伤

Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-08-14

基于DILIN网络2004至2018年1418例患者,鉴定22例藤黄果相关肝损伤(5例单用,16例联用绿茶,1例联用Ashwagandha)。肝损伤呈肝细胞型伴黄疸,91%住院,1例死亡、1例肝移植;HLA-B*35:01等位基因频率显著高于其他HDS及常规药物肝损伤。

要点

  • 藤黄果相关肝损伤多为肝细胞型伴黄疸,91%需住院,可致死亡或肝移植。
  • HLA-B*35:01等位基因在藤黄果HDS肝损伤中频率显著升高,提示免疫介导机制。
  • 藤黄果单用或联用绿茶所致肝损伤临床无法区分。

核心结论

  • 藤黄果单独或与绿茶联用所致肝损伤临床无法区分,呈肝细胞型伴黄疸,可致死亡或肝移植。
  • HLA-B*35:01等位基因与藤黄果HDS肝损伤显著相关,提示免疫介导机制。

研究设计与样本

  • 基于DILIN网络2004至2018年1418例患者,鉴定22例藤黄果相关肝损伤(单用5例,联用绿茶16例,联用Ashwagandha 1例)。
  • 对照组为57例含绿茶但不含藤黄果的HDS肝损伤患者和103例其他HDS肝损伤患者。

主要发现

  • 藤黄果组患者年龄17至54岁,肝损伤发生于开始服用后13至223天(中位51天)。
  • 1例死亡,1例需肝移植,91%住院;肝损伤为肝细胞型伴黄疸。
  • 藤黄果组转氨酶峰值显著更高(2001±1386 U/L,P<.018)。
  • 藤黄果组总胆红素改善中位时间显著更短(10天 vs 17天和13天,P=.03)。
  • HLA-B*35:01等位基因频率在含藤黄果HDS组为55%,显著高于其他HDS组19%(P=.002)和常规药物急性肝损伤组12%(P=2.55×10-6)。

临床怎么用

  • 对服用藤黄果(尤其联用绿茶)的肝损伤患者,应考虑药物性肝损伤并详细追问HDS史。
  • HLA-B*35:01等位基因检测可能有助于识别藤黄果相关肝损伤高风险个体。

局限性

  • 样本量小(22例),来自单一时网络,可能存在选择偏倚。
  • 未报告剂量-反应关系及机制验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Garcinia cambogia, either alone or with green tea, is commonly promoted for weight loss. Sporadic cases of liver failure from G cambogia have been reported, but its role in liver injury is controversial. METHODS: Among 1418 patients enrolled in the Drug-Induced Liver Injury Network (DILIN) from 2004 to 2018, we identified 22 cases (adjudicated with high confidence) of liver injury from G cambogia either alone (n = 5) or in combination with green tea (n = 16) or Ashwagandha (n = 1). Control groups consisted of 57 patients with liver injury from herbal and dietary supplements (HDS) containing green tea without G cambogia and 103 patients from other HDS. RESULTS: Patients who took G cambogia were between 17 and 54 years, with liver injury arising 13-223 days (median = 51) after the start. One patient died, one required liver transplantation, and 91% were hospitalized. The liver injury was hepatocellular with jaundice. Although the peak values of aminotransferases were significantly higher (2001 ± 1386 U/L) in G cambogia group (P < .018), the median time for improvement in total bilirubin was significantly lower compared with the control groups (10 vs 17 and 13 days; P = .03). The presence of HLA-B∗35:01 allele was significantly higher in the G cambogia containing HDS (55%) compared with patients because of other HDS (19%) (P = .002) and those with acute liver injury from conventional drugs (12%) (P = 2.55 × 10-6). CONCLUSIONS: The liver injury caused by G cambogia and green tea is clinically indistinguishable. The possible association with HLA-B∗35:01 allele suggests an immune-mediated mechanism of injury. CLINICAL TRIALS: gov number: NCT00345930.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Vuppalanchi R, Bonkovsky HL, Ahmad J, et al. Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol. 2021. PMID: 34400337. doi:10.1016/j.cgh.2021.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。